Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib

Affiliations

• ¹ Department of Paediatric Oncology, Comprehensive Cancer Centre, King Fahad Medical, Riyadh, Saudi Arabia.
• ² Radiation Oncology Department, Comprehensive Cancer Centre, King Fahad Medical City, Riyadh, Saudi Arabia.
• ³ Department of Clinical Pharmacy, King Fahad Medical City, Riyadh, Saudi Arabia.
• ⁴ Radiology Department, King Fahad Medical City, Riyadh, Saudi Arabia.
• ⁵ Foundation Medicine, Morrisville, NC.
• ⁶ Wake Forest Comprehensive Cancer Center and Department of Pathology, Wake Forest School of Medicine, Winston-Salem, NC.
• ⁷ Genomics Research Department, Saudi Human Genome Project, King Fahad Medical City and King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia.